{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T14:38:02Z","timestamp":1648651082118},"reference-count":20,"publisher":"Pharmaceutical Society of Japan","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2019,8,1]]},"DOI":"10.1248\/bpb.b19-00099","type":"journal-article","created":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T18:03:24Z","timestamp":1564596204000},"page":"1419-1422","source":"Crossref","is-referenced-by-count":0,"title":["Adverse Reaction of Dextran Sodium Sulfate-Induced Colitis in a Collagen-Induced Mouse Arthritis Model"],"prefix":"10.1248","volume":"42","author":[{"given":"Kenji","family":"Goto","sequence":"first","affiliation":[{"name":"Laboratory of Clinical Pharmacology, Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science"},{"name":"Laboratory of Pathophysiology and Pharmacotherapy, Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Hiramoto","sequence":"additional","affiliation":[{"name":"Laboratory of Pathophysiology and Pharmacotherapy, Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Ooi","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pharmacology, Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science"},{"name":"Laboratory of Pathophysiology and Pharmacotherapy, Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) The Lancet. Inflammatory bowel diseases audited. <i>Lancet<\/i>, <b>379<\/b>, 868 (2012).","DOI":"10.1016\/S0140-6736(12)60376-6"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. <i>Lancet<\/i>, <b>376<\/b>, 1094\u20131108 (2010).","DOI":"10.1016\/S0140-6736(10)60826-4"},{"key":"3","unstructured":"3) Bae JM, Choo JY, Kim KJ, Park KS. Association of inflammatory bowel disease with ankylosing spondylitis and rheumatoid arthritis: a nationwide population-based study. <i>Mod. Rheumatol.<\/i>, <b>27<\/b>, 435\u2013440 (2017)."},{"key":"4","unstructured":"4) Cruz VA, Yamaguchi L, Ribeiro CN, Magalh\u00e3es Vde O, Rego J, Silva NA. Ulcerative colitis and rheumatoid arthritis: a rare association\u2014Case report. <i>Rev. Bras. Reumatol.<\/i>, <b>52<\/b>, 648\u2013650 (2012)."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Y\u00fcksel I, Ataseven H, Ba\u015far O, K\u00f6kl\u00fc S, Ertu\u011frul I, Ulker A, Da\u011fl\u0131 U, Sa\u015fmaz N. Peripheral arthritis in the course of inflammatory bowel diseases. <i>Dig. Dis. Sci.<\/i>, <b>56<\/b>, 183\u2013187 (2011).","DOI":"10.1007\/s10620-010-1260-z"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Goto K, Hiramoto K, Kawakita M, Yamaoka M, Ooi K. The influence of reactive oxygen species and glucocorticoids on dry skin in a mouse model of arthritis. <i>Skin Pharmacol. Physiol.<\/i>, <b>31<\/b>, 188\u2013197 (2018).","DOI":"10.1159\/000488250"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Goto K, Hiramoto K, Ooi K. Th2 and Th17 induce dry skin in a mouse model of arthritis. <i>Biol. Pharm. Bull.<\/i>, <b>42<\/b>, 468\u2013474 (2019).","DOI":"10.1248\/bpb.b18-00803"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Yokoyama S, Hiramoto K, Koyama M, Ooi K. Impairment of skin barrier function <i>via<\/i> cholinergic signal transduction in a dextran sulphate sodium-induced colitis mouse model. <i>Exp. Dermatol.<\/i>, <b>24<\/b>, 779\u2013784 (2015).","DOI":"10.1111\/exd.12775"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Hiramoto K, Yamate Y, Kasahara E, Sato EF. An inhibitor of casein kinase 1\u03b5\/\u03b4 (PF670462) prevents the deterioration of dextran sodium sulfate-induced ulcerative colitis caused by UVB eye irradiation. <i>Int. J. Biol. Sci.<\/i>, <b>14<\/b>, 992\u2013999 (2018).","DOI":"10.7150\/ijbs.24558"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Nishimura T, Andoh A, Hashimoto T, Kobori A, Tsujikawa T, Fujiyama Y. Cellobiose prevents the development of dextran sulfate sodium (DSS)-induced experimental colitis. <i>J. Clin. Biochem. Nutr.<\/i>, <b>46<\/b>, 105\u2013110 (2010).","DOI":"10.3164\/jcbn.09-72"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Mazzon E, Cuzzocrea S. Absence of functional peroxisome proliferator-activated receptor-alpha enhanced ileum permeability during experimental colitis. <i>Shock<\/i>, <b>28<\/b>, 192\u2013201 (2007).","DOI":"10.1097\/SHK.0b013e318033eb29"},{"key":"12","unstructured":"12) Mateen S, Moin S, Shahzad S, Khan AQ. Level of inflammatory cytokines in rheumatoid arthritis patients: correlation with 25-hydroxy vitamin D and reactive oxygen species. <i>PLOS ONE<\/i>, <b>12<\/b>, e0178879 (2017)."},{"key":"13","unstructured":"13) Li HB, Chen MY, Qiu ZW, Cai QQ, Li DT, Tang HM, Chen XL. Efficacy and safety of Kangfuxin liquid combined with aminosalicylic acid for the treatment of ulcerative colitis: a systematic review and meta-analysis. <i>Medicine<\/i> (Baltimore), <b>97<\/b>, e10807 (2018)."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Kofla-D\u0142ubacz A, Matusiewicz M, Krzesiek E, Noga L, Iwa\u0144czak B. Metalloproteinase-3 and -9 as novel markers in the evaluation of ulcerative colitis activity in children. <i>Adv. Clin. Exp. Med.<\/i>, <b>23<\/b>, 103\u2013110 (2014).","DOI":"10.17219\/acem\/37031"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Wang ZY, Qiu BF. Increased expression of matrix metalloproteinase-1 and 3 in remission patients of steroid-dependent ulcerative colitis. <i>Gastroenterology Res.<\/i>, <b>3<\/b>, 120\u2013124 (2010).","DOI":"10.4021\/gr2010.05.208w"},{"key":"16","unstructured":"16) Ribbens C, Martin y Porras M, Franchimont N, Kaiser MJ, Jaspar JM, Damas P, Houssiau FA, Malaise MG. Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment. <i>Ann. Rheum. Dis.<\/i>, <b>61<\/b>, 161\u2013166 (2002)."},{"key":"17","unstructured":"17) Atreya R, Mudter J, Finotto S, M\u00fcllberg J, Jostock T, Wirtz S, Sch\u00fctz M, Bartsch B, Holtmann M, Becker C, Strand D, Czaja J, Schlaak JF, Lehr HA, Autschbach F, Sch\u00fcrmann G, Nishimoto N, Yoshizaki K, Ito H, Kishimoto T, Galle PR, Rose-John S, Neurath MF. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis <i>in vivo.<\/i> <i>Nat. Med.<\/i>, <b>6<\/b>, 583\u2013588 (2000)."},{"key":"18","unstructured":"18) Mizoguchi A, Mizoguchi E. Inflammatory bowel disease, past, present and future: lessons from animal models. <i>J. Gastroenterol.<\/i>, <b>43<\/b>, 1\u201317 (2008)."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Louis E, Ribbens C, Godon A, Franchimont D, De Groote D, Hardy N, Boniver J, Belaiche J, Malaise M. Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease. <i>Clin. Exp. Immunol.<\/i>, <b>120<\/b>, 241\u2013246 (2000).","DOI":"10.1046\/j.1365-2249.2000.01227.x"},{"key":"20","unstructured":"20) Silo\u015fi I, Boldeanu MV, Mogoant\u0103 S\u015e, Ghilu\u015fi M, Cojocaru M, Biciu\u015fc\u0103 V, Cojocaru IM, Avr\u0103mescu CS, Gheonea DI, Silo\u015fi CA, Turculeanu A. Matrix metalloproteinases (MMP-3 and MMP-9) implication in the pathogenesis of inflammatory bowel disease (IBD). <i>Rom. J. Morphol. Embryol.<\/i>, <b>55<\/b>, 1317\u20131324 (2014)."}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/42\/8\/42_b19-00099\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T23:22:49Z","timestamp":1564788169000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/42\/8\/42_b19-00099\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,1]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b19-00099","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,1]]}}}